Vivos Therapeutics is a medical device and services company that develops and markets proprietary oral appliances—including its flagship DNA, mRNA, and mmRNA devices—designed to treat obstructive sleep apnea and snoring through a comprehensive therapeutic program typically spanning 12–15 months. The company's core business historically centered on training and enrolling dentists to distribute its products directly, but has shifted toward acquiring and partnering with sleep specialty centers and medical practices to expand patient reach and create integrated treatment ecosystems. Revenue is generated through a mix of product sales (oral appliances and pediatric tooth positioners), diagnostic and sleep testing services, treatment center operations, and ancillary offerings including myofunctional therapy, billing optimization, and professional training, with the company operating primarily across North America while pursuing selective geographic expansion in the West and Midwest.